Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin‐like growth factor (IGF)‐I expression in bronchial asthma
- 1 May 1998
- journal article
- clinical trial
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 28 (5) , 568-577
- https://doi.org/10.1046/j.1365-2222.1998.00277.x
Abstract
Pathological studies of bronchial biopsy specimens have confirmed the apparent thickening of lamina reticularis of the epithelial basement membrane. Corticosteroids have proven to be most effective in modifying airway inflammation. However, there is not much data on the effects of corticosteroid-treatment on the basement membrane. To investigate the effects of inhaled beclomethasone dipropionate (BDP) on the thickness of basement membrane and cellular infiltration into the bronchial mucosa, and the expression of growth factors in patients with asthma. We studied bronchial biopsies from 24 asthmatic patients before and after treatment with inhaled BDP, 400 μg twice a day or placebo, for 6 months in a double-blind manner. Each subject recorded daily asthma symptoms and peak expiratory flow (PEF). Lung function and bronchial responsiveness to methacholine were measured before and after treatment. The thickness of the basement membrane was determined by electron microscopy. Inflammatory cells and the expression of growth factors were examined by immunohistochemistry in endobronchial biopsy specimens. After 6 months of treatment, we observed a significant improvement of asthma symptoms (P < 0.01), PEF (P < 0.01), diurnal variation of PEF (P < 0.05), and airway responsiveness (P < 0.05) in the BDP group compared with the placebo group. This was accompanied by a significant decrease in the thickness of the lamina reticularis (P < 0.001), and in the number of activated eosinophils (P < 0.01), T-lymphocytes (P < 0.01), and fibroblasts (P < 0.05) in BDP-treated patients. There was also a reduction in the expression of insulin-like growth factor (IGF)-I (P < 0.01). Significant correlation was found between the IGF-I expression and collagen thickening (rs = 0.34, P < 0.01), and the number of fibroblasts (rs = 0.45, P < 0.01). These results suggest that corticosteroid treatment in asthma can reduce the lamina reticular thickness by modulation of IGF-I expression with consequent inhibition of the airway infiltration by inflammatory cells, and therefore may help to prevent remodelling of the airways.Keywords
This publication has 48 references indexed in Scilit:
- Transforming growth factor beta 1 gene expression in human airways.Thorax, 1994
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung.Annals of the Rheumatic Diseases, 1992
- Eosinophils adhere to and stimulate replication of lung fibroblasts ‘in vitro’Clinical and Experimental Immunology, 1991
- Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.The Journal of Experimental Medicine, 1989
- Exaggerated Spontaneous Release of Platelet-Derived Growth Factor by Alveolar Macrophages from Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1987
- Cellular Localization of Somatomedin (Insulin-Like Growth Factor) Messenger RNA in the Human FetusScience, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Monoclonal antibodies to human prolyl 4-hydroxylaseEuropean Journal of Biochemistry, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981